Announced Mon, 25 May · 17:37 IST

The Annual Secretarial Compliance Report for the year ended 31 March 2026 issued by Ms. Prajakta V. Padhye, Partner of Nilesh A. Pradhan & Co. LLP, Practising Company Secretaries, Mumbai

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+9.6%1-day move
₹119.00
prior close
₹121.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.6-0.8+0.0-1.7+9.6+14.2+9.8+7.6+5.5+5.0+0.6+9.7-7.7
Up moveDown movePending
AI summary

Aspira Pathlab & Diagnostics Ltd has submitted its Annual Secretarial Compliance Report for FY2025-26, as mandated under SEBI Regulation 24A. The report was issued by Nilesh A. Pradhan & Co. LLP, Practising Company Secretaries, Mumbai. The secretarial auditor examined compliance with key SEBI regulations including LODR 2015, SAST 2011, and PIT Regulations 2015. The company has been found to be in full compliance across all 13 parameters examined, including secretarial standards, board policies, website disclosures, director disqualification status, related party transactions, insider trading norms, and preservation of documents. No deviations, observations, or penalties were reported. Annexure A and B, which would list any violations or remedial actions, are marked as 'Not Applicable', indicating a clean compliance record for the year.

Likely market impact

This is a positive regulatory compliance disclosure confirming the company has maintained good governance standards. The clean bill of health from secretarial auditors should provide comfort to investors regarding the company's adherence to SEBI listing requirements.